Skip to main content
  • Research article
  • Open access
  • Published:

Claims, liabilities, injures and compensation payments of medical malpractice litigation cases in China from 1998 to 2011



Although China experienced great improvement in their health system, disputes between patients and doctors have increasingly intensified, reaching an unprecedented level. Retrospective analysis of medical malpractice litigation can discover the characteristics and fundamental cause of these disagreements.


We analyzed medical malpractice litigation data from 1998 to 2011 for characteristics of claims via a litigation database within a nationwide database of cases (1086 cases) in China, including claims, liabilities, injures, and compensation payments.


Among the cases analyzed, 76 percent of claims received compensation in civil judgment (640 out of 841), while 93 percent were fault liability in paid judgment (597 out of 640). The average time span between the occurrence of the injury dispute and closure of claims was 3 years. Twenty-two percent of claims (183 of 841) were caused by injury, poisoning, and other external causes. Seventy-nine percent of claims (472 of 597) were contributed to by errors in medical technology. The median damage compensation payment for death was significantly lower than for serious injuries (P < 0.001; death, $13270 [IQR, $7617–$23181]; serious injury, $23721 [IQR, $10367–$57058]). Finally, there was no statistically significant difference in the median mental compensation between minor injury, serious injury, and death (P = 0.836).


The social reasons for the conflict and high payment were catastrophic out-of-pocket health-care expense in addition to the high expectations for treatment in China. There were no distinguishing features between China and other countries with respect to time of suits, facilities, and specialties in these claims. The compensation for damages in different medical injuries was unfair in China.

Peer Review reports


Although China has greatly improved on their health and medicine system, disputes between patients and doctors have increasingly intensified, reaching an unprecedented level. Many factors contribute to the conflicts [13] between doctors and patients, including the high health care costs, unreasonable prescription, [1] preventative medicine [4], and unnecessary examinations [3]. Poor investment in the health system and in training and paying doctors in China can lead to medical errors, corruption, and poor communication between doctors and patients [5]. The malpractice disputes occur both in China [6, 7] and other countries [811]. Beside eroding the trust [8] between patients and doctors, medical disputes and errors spawned a great deal of economic loss [10]. Several studies have estimated that approximately one RMB in malpractice compensation may be an additional indirect cost leading to hospital losses of 6.7 times more [12]. Though there have been numerous reports or studies on malpractice in China, studies seldom focus on malpractice litigation in China. However, this may be due to the fact that compensation data related to different injuries is not easily available either in China or other countries.

In this study, we investigated the outcomes of malpractice litigation according to structured retrospective reviews of 1086 closed claims from 1998 to 2011 in China. Results from our detailed analyses of patient claims could provide valuable insights into malpractice litigation in China and make significant contributions to both the safety of patients and management of litigation risk.

The malpractice laws in china

In China, there are three legislative regulations on medical malpractice. The first is the Rule on the Handling of Medical Accident from 1987 to 2002. The second is the Regulations on the Handling of Medical Accident since 2002. The 2002 regulation replaces the previous 1987 regulation and increases the adequacy and fairness of compensation as well as the procedure for resolving medical disputes [6]. The third regulation is the Chapter Six Liability for Medical Malpractice of the Tort Law of the People’s Republic of China, which was adopted by the Standing Committee of the National People’s Congress on December 26, 2009 and became effective on July 1, 2010.


Study sites

We analyzed 1087 claims settled from February 1998 to October 2011 in 29 provinces of China, using a medical malpractice civil litigation database (civil ruling, civil judgment, and civil mediation) from, provided by ChinalawinfoCo. Ltd., Peking University Center for Legal Information. The database is considered of high authority and is distributed and used widely by law professionals throughout China. More importantly, it is admitted by the Supreme People’s Court of China since 2003—Chinese Justice Legal Application Support System (CJLASS) database. All 1086 closed claims in the CJLASS database were allocated to “liability for medical malpractice disputes”. Cases before 1998 were not thoroughly documented with all of the statistical information needed for this study; thus, they were excluded from this study. This study was designed to be a retrospective case study. We intended to find out the characteristics of medical malpractice litigants in China.

We are permitted to access to the database used in our study by ChinalawinfoCo.Ltd. Our study had the approval of the ethics committee of Harbin Medical University of China.

Statistical analysis

The data sheets, which had been filled out by hand, were electronically entered into a database and verified by a professional data-entry vendor.

We examined characteristics of the court, procedure, appellant, type of medical facility in our samples, percentage of the medical specialties, classification of diseases, injury, degree of liability, and concurrence of causes. We reported the expense in litigation, amount of compensation paid, and days of litigation by using mean value and confidence interval as well as the median and interquartile range. We compared characteristics of errors and injuries, using percentage agreement to determine the probability.

We used the Wilcoxon Rank-Sum test to study bivariate associations of the liability, damage, and mental compensation payment in medical malpractice litigation judgment. Subsequently, analyses were conducted with the use of the PASW Statistics software packages, version 18.0.

For our cross-sectional analysis, we limited our sample to claims paid in 2011, because this was the most recent year with complete data available. Hereafter, the amounts shown are estimated based on $US 1 = ¥RMB 6.34.

Criteria for coding and definition

Civil ligations have three results in China: “civil ruling”, “civil judgment”, and “civil mediation in court”. A civil ruling is the processing of a result of the procedure problem and does not address the rights and obligations to the defendant-plaintiff. Civil judgment is a verdict by the judge about the malpractice dispute and addresses the rights and obligations to the defendant-plaintiff. Civil mediation is a compromise by the defendant-plaintiff in court.

Hospitals bear the liability in three ways: “liability for breach of contract”, “fault liability”, and “equitable liability”. Liability for breach of contract means that the hospital undertakes the responsibility of a breach of medical service contract with a patient. Fault liability means that the hospital undertakes the liability based on some degree of responsibility. Equitable liability means that although the hospital is not at fault, it provides appropriate compensation for the injured patients as per its current property status.

In our study, “type of medical facility” classified medical facilities into 13 categories according to article three of the Rules for the Implementation of the Regulations on the Administration of Medical Institutions in China.

“Classification of diseases” classified diseases into 23 categories according to the International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10) used by the World Health Organization (WHO).

“Degree of liability” divided liability into five circumstances: “full liability” (hospital accepts 100% liability for patient’s injury), “ultimate liability” (hospital accepts 50%–100% liability), “equal liability” (hospital accepts 50% liability), “secondary liability” (hospital accepts 10%–50% liability), and “minor liability” (hospital accepts <10% liability).

“Concurrence of causes” meant that the hospital’s errors contributed to the patient’s injury. Other causes were “cause of patients and families”, “third person tort and hospital joint infringement”, and “multiple medical institutions joint infringement”.

“Medical error” was classified into “medical technology error” (containing nine common subcategories, e.g., surgery, drugs used, diagnose, treatment related errors, etc.), “medical ethics error” (including infringement of patients’ informed consent or privacy), “medical product error” (means the hospital used defective or unqualified blood and blood products, medical equipment, and drugs, causing the injury), and “medical management error” (including administrative, medical record-related, and risk-related management errors).

We measured “injury” by combining the ten divisions on the basis of disability levels, which were ruled on in the Medical Accident Grading Standard in China (for Trial Implementation), into four categories: “minor injury” (injury below the six disability level; life cannot be managed independently), “serious injury” (one to six disability level; most or part of life cannot be managed independently), “death”, and “emotional injury only”.


Relationship between compensation and liability

Seventy-seven percent of the litigation cases fell into the judgment category (Figure 1). Most claims received compensation in judgment (640 of 841 [76 percent]) and in mediation (90 of 91 [99 percent]). The outcomes of the payment claims in judgment consisted of three types: breach-of-contract liability (4 of 640 [0.6 percent]); fault liability (597 of 640 [93 percent]), in which the liability was based on some degree of responsibility; and equitable liability (39 of 640 [6 percent]), in which there was a kind of distribution of responsibility and both parties thereto were found to be without fault. Therefore, fault liability is the dominant category in the majority of the claims.

Figure 1
figure 1

Overview of the relationship among malpractice disputes, judicial records, outcomes of litigation and form of liability.

Characteristics of claims

Seventy-four percent of the claims were solved by an intermediate court (Table 1). Seventy-one percent were closed after the second trial, and 22 percent were closed after the first trial. In 78 percent of cases (n = 844), the appellant—either hospital (31 percent), patient (56 percent), or both (13 percent)—appealed the case.

Table 1 Characteristics of 1086 Claims

Eighty-four percent of the claims were closed between 2006 and 2011, while 39 percent were closed in 2010 or later. Eighty-three percent of the claims took place in the midland and east of China. The average expense of litigation per claim was $1224 (median, $804). The expenses of plaintiff burden, on average, were nearly the same as the defendants’ burden (roughly about $590 vs. $639). The average length of time between the occurrence of the injury dispute and closure of claims was three years (median, two years).

General hospitals were the most frequently sued by the patient in these cases (66 percent), followed by township hospitals (10 percent) and traditional Chinese medicine hospitals (6 percent). Disciplines such as obstetrics and gynecology, orthopedics, and general surgery accounted for the majority of medical specialties involved in the medical malpractice claims (53 percent). Among patients admitted to the hospital, 22 percent of issues were caused by injury, poisoning, and certain other external causes. Sixteen percent were due to pregnancy, childbirth, and the puerperium (16 percent), while 11 percent were caused by diseases of the digestive system.

Among the fault liability with pay claims (n = 597), 66 percent burdened the hospital with full, ultimate, or equal liability. While 75 percent of the claims were concurrence of causes for the injury (n = 447), 77 percent of the concurrent causes were between self-injury by patient or family and hospital infringement for the injury. Secondarily, 17 percent of the concurrent causes were due to either the third person tort or the hospital joint infringements. Finally, six percent of concurrent causes were due to joint infringement by multiple medical institutions.

Contributing factors

There were four major factors contributing to the injuries: medical technology error (79 percent), medical ethics error (7 percent), medical product error (7 percent), and medical management error (7 percent) (Table 2). Minor injuries (44 percent) and death (34 percent) were the most frequent outcomes in the malpractice claims. Serious injury (20 percent) and emotional injury (2 percent) are the secondary outcomes.

Table 2 Contributing factors associated with medical error by injury

Compensation payment

There was no statistically significant difference in the median compensation payments between the civil mediation and the civil judgment groups (P = 0.125) (Table 3). Similarly, there was no statistically significant difference in the mental compensation payments between minor injury, serious injury, and death groups (P = 0.836).The median liability compensation payment for fault liability was significantly higher than that of equal liability (P < 0.001; fault liability, $11611 [IQR, $5764–$24894]; equal liability, $2549 [IQR, $1087–$11376]).The median damage compensation payment for death was significantly lower than that for serious injury (P < 0.001; death, $13270 [IQR, $7617–$23181]; serious injury, $23721 [IQR, $10367–$57058]). The maximum payment occurred in minor injury case, fault liability in civil judgment ($628692). In 18 percent of claims (106 of 597), no mental compensation was awarded for injury (minor injury, n = 44; serious injury, n = 25; death, n = 37).

Table 3 The compensation payment in medical malpractice litigation, 2011*


Conflict between patient and doctor

Research data show that medical disputes increase from year to year. There are a number of reasons for the increase in doctor-patient conflict. With advances in healthcare-related science and technology, patients have unrealistic expectations about treatment, so the physician is more frequently called to answer for any result falling short of patient expectations [10]. This is the common reason both in China and other countries [13], like Italy [10].

In addition, due to poor investment and dramatic marketization of the health system in China, Chinese patients generally spend more than half of their received compensation from medical litigations on their medical costs instead of receiving full coverage from their health insurance companies.

As Liebman and Lancet report, families have had to pay out of pocket up front for healthcare—a phenomenon referred to as “pay or die” [1] or “catastrophic expenses” [5] in China. This special social issue worsens the relationship between doctor and patient.

On the other hand, involved hospitals are also in an unfortunate situation, in which they have to cover expenses for patients’ compensation from medical litigation. This is in contrast with the situation in other countries in which the cost is covered by medical liability insurance companies. In other words, both the patients and the hospitals bear the huge economic burdens of medical malpractice disputes and become direct opposition parties.

Payment of malpractice claims

After comprehensive analysis of litigation data, we concluded that the majority of claims were generally resolved appropriately through medical malpractice litigation. When combining payment claims for civil judgment and civil mediation together, approximately two thirds of claims (67 percent) resulted in payment. In addition, almost all of the mediated claims in court resulted in compensation payment. However, only a small fraction of claims were solved on monetary compensation without admission of errors by hospitals.

Several previous studies in China and other countries have investigated the outcomes of malpractice claims [1430]. Their findings vary widely, with 64 to 90 percent of claims judged to result in financial compensation in China [17, 18] and about 25 to 65 percent of claims in the USA [1416] and other countries resulting in monetary rewards. While informative, each of these Chinese studies contains some flaws—for instance, use of smaller numbers of claims (73 to 356 cases) [19, 20] in the study or narrow focus on a single hospital [19], area [21], or specialty [22, 31], and analysis of a single type of error [23]. A similar situation existed in the USA [2427, 32], England [28, 29], Japan [30], and France [33]. In addition, most of the Chinese studies did not address the issue of compensation [19, 20, 22, 23]. Our study was designed to avoid these limitations and to conduct a comprehensive analysis. In William B. Weeks’ study, researchers found that financial compensation was made in 65 percent cases [16]. David analyzed 1452 litigation claims and found that, in 55 percent cases, patients received payment [15]. We discovered that a similar proportion of claims (67 percent) received financial compensation in our study. However, a much lower percentage of cases were solved in settlement in court (8 percent) than in William B. Weeks’ study (61 percent). A low percentage of settlements indicates the presence of more intense conflicts between patients and hospitals in China.

The burden of malpractice litigation

We identified a small difference in the outcomes of litigation for claims, specifically in the duration from the dispute to closure of the litigation. On average, it takes about two years [34] (three years in our study) in China and five years [15] in the USA to complete a litigation, which is longer than the time consumed in the cases of settlement out of court (about 1 year both in China [34] and the USA [16]). These periods are long for plaintiffs to receive final decisions on monetary compensation [15]. However, the prolonged litigation time was a relatively small impacting factor for the defendants in China, where doctors are allowed to work in hospitals normally during the period of litigation. This practice was quite different from that in the USA [15], where doctors involved in lawsuits are not allowed to work during the litigation period. Unfortunately, patients tend to resort to extreme violence in medical disputes in China when they perceive that doctors have poor attitude and lower quality of medical services. Lenient punishments for doctors may partially account for the violence in these medical disputes.

Reasons for high-risk medical specialties

Our results in type of medical facilities, medical specialties in claims have few distinguishing characteristics compared to other studies. The majority of malpractice disputes in China occur in general hospitals and township hospitals [35]. Obstetrics and gynecology, orthopedics, and general surgery are always the top three medical-risk specialties, both in China [12, 17, 20, 3437] and in the USA [15, 32]. Similar results were found in Taiwan that malpractice experiences were more frequent in physicians of surgery or obstetrics and gynecology [38]. This phenomenon can be attributed to three factors. First, obstetrics and gynecology deal with newborns or the female reproductive system, and orthopedics handles body movement and work competence. These tend to grab more attention from patients and their families [39]. Second, patients who are admitted to surgery departments often suffer from severe diseases and expect dramatic improvements following a major procedure. Third, surgical procedures are more dramatic and may encounter more risk than other specialties.

Diseases and liability in litigation cases

We found unexpected outcomes of disease and liability in litigation cases. Injury, poisoning, and certain other external causes were the main issues involved in these claims. The majority of the patients’ injuries had concurrent infringement by other subjects, not only by one hospital. In other words, these medical malpractice claims occurred with greater complexity. In essence, there is no guarantee of completely avoiding or preventing medical risks in China. Furthermore, we found a stark difference in the outcome of degree liability between those settled in court and those settled out of court. The percentage of full liability and ultimate liability was dramatically higher in litigations settled in court (60 percent) than those resolved out of court (8.4 percent) [20]. These results suggest that secondary and minor liability claims are easy to reconcile out of court.

Errors contribute to injuries

When analyzing the results of errors and injuries, we found that the medical technology errors were certainly the most frequent causes of injuries, rather than errors of staff ethics or management of diseases. Nevertheless, more than half of plaintiffs still questioned the authenticity of medical documents in claims. In fact, some hospitals may forge or change medical documents to cover up their errors. Hospitals hold controlled access to patients’ records and, more often than not, deny patients access to their own medical records. This does underline the challenges in reality that a plaintiff faces when trying to access and acquire evidential information that is crucial for the proof of the claim [40]. In other words, this was the deep-rooted reason for the “malpractice crisis” in China: the lack of a credible system to deal with medical malpractice and to solve related problems in quality of medical care [6].

Unfair compensation in medical malpractice

We should pay attention to the unjust consequences of various compensation payments for different injuries. The average payment for serious injury ($23721) was more than twice the payment made at death of a patient ($13270). In the Chinese compensation provisions, there is stipulation on the disability compensation but no provision on death compensation. The death compensation stipulation was only introduced in 2010 when the Tort Liability Act, which was responsible for the lower payment in the event of death, was introduced. Additionally, the compensation for moral damages has been legislatively limited or “capped” for plaintiffs in malpractice cases by Chinese legal provisions for compensation [1, 41], which may be the reason for the similarity in compensation among different injuries. These unreasonable and unfair consequences can be mainly attributed to deficiencies or flaws of medical malpractice law in China.


We recognize that our study may contain the following limitations. First, samples were drawn from a legal precedent website involved in medical disputes. These samples may not fully represent malpractice claims nationwide. Other research reported that about 5.4 to 25.3 percent of medical disputes were solved by litigation in all claims [17, 18, 34, 36, 38]. Second, we do not have detailed information on either doctors or patients involved in these litigation cases. Third, the practice of assigning categories in our judgments may not be totally reliable, since arbitrary assignment of categories may not fully represent the complexity of malpractice claims. Fourth, we did not take the liability factor into consideration when comparing compensation amounts in different injuries.


The social reasons for the conflict and high payment were catastrophic out-of-pocket health-care expense in addition to the high expectations for treatment in China. There were no distinguishing features between China and other countries with respect to time of suits, facilities, and specialties in these claims. The compensation for damages in different medical injuries was unfair in China.


  1. Liebman BL: Malpractice mobs: medical dispute resolution in China. Columbia Law Rev. 2013, 113 (1): 181-264.

    Google Scholar 

  2. The WQ: China’s Medical Mayhem. Wilson Quarterly. 2013, 37 (3): 144-146.

    Google Scholar 

  3. The L: Chinese doctors are under threat. Lancet. 2010, 376: 657-657. 10.1016/S0140-6736(10)61315-3.

    Article  Google Scholar 

  4. Chen X: Defensive medicine or economically motivated corruption? A confucian reflection on physician care in china today. J Med Philos. 2007, 32 (6): 635-648. 10.1080/03605310701681021.

    Article  PubMed  Google Scholar 

  5. The L: Ending violence against doctors in China. Lancet. 2012, 379 (9828): 1764.

    Google Scholar 

  6. Harris DM, Wu CC: Medical Malpractice in the People’s Republic of China: The 2002 Regulation on the Handling of Medical Accidents. J Law Med Ethics. 2005, 33 (3): 456-477. 10.1111/j.1748-720X.2005.tb00512.x.

    Article  PubMed  Google Scholar 

  7. Chang L: In China, Courts Find New Muscle as They Take On Medical Cases. (Cover story). Wall Street J Eastern Edition. 2002, 239 (4): A1.

    Google Scholar 

  8. Feldman EA: Why Patients Sue Doctors: The Japanese Experience. J Law Med Ethics. 2009, 37 (4): 792-799. 10.1111/j.1748-720X.2009.00450.x.

    Article  PubMed  Google Scholar 

  9. Wheat K: Is There a Medical Malpractice Crisis in The UK?. J Law Med Ethics. 2005, 33 (3): 444-455. 10.1111/j.1748-720X.2005.tb00511.x.

    Article  PubMed  Google Scholar 

  10. Francesco T: Medical Malpractice: The Experience in Italy. Clin Orthop Relat Res. 2009, 467 (2): 434-442. 10.1007/s11999-008-0582-z.

    Article  Google Scholar 

  11. Bal B: An Introduction to Medical Malpractice in the United States. Clin Orthop Relat Res. 2009, 467 (2): 339-347. 10.1007/s11999-008-0636-2.

    Article  PubMed  Google Scholar 

  12. Wang D, Yang Y: Retrospective Analysis on 315 Cases of Medical Dispute In a General Hospital. Sun Yatsen University Forum. 2007, 27 (11): 32-36.

    Google Scholar 

  13. The L: Violence against doctors: Why China? Why now? What next?. The Lancet. 2014, 383 (9922): 1013-10.1016/S0140-6736(14)60501-8.

    Article  Google Scholar 

  14. Neil V: Juries and Medical Malpractice Claims: Empirical Facts versus Myths. Clin Orthop Relat Res. 2009, 467 (2): 367-375. 10.1007/s11999-008-0608-6.

    Article  Google Scholar 

  15. Studdert DM, Mello MM, Gawande AA, Gandhi TK, Kachalia A, Yoon C, Puopolo AL, Brennan TA: Claims, Errors, and Compensation Payments in Medical Malpractice Litigation. New Engl J Med. 2006, 354: 2024-2033. 10.1056/NEJMsa054479.

    Article  CAS  PubMed  Google Scholar 

  16. Weeks WB, Foster T, Wallace AE, Stalhandske E: Tort Claims Analysis in the Veterans Health Administration for Quality Improvement. J Law Med Ethics. 2001, 29 (3/4): 335.

    Article  CAS  PubMed  Google Scholar 

  17. Zhu Z, Jiang B: To Discuss The Necessity of Establishing a Medical Identification System of Medical Disputes- Report of 62 Cases of Medical Dispute Lawsuit Case Analysis. Jiangsu Health Management. 2007, 18 (97): 78-80.

    Google Scholar 

  18. Yu B, Chen C, Jin X, Sun J, Xu H: Disposal of 278 Medical Dispute Cases. Hosp Admin J Chin Chin PLA. 2012, 19 (10): 966-967.

    Google Scholar 

  19. Lu H, Wang H: Reasons of 73 medical dispute cases. J Chinese PLA Postgrad Med Sch. 2010, 31 (8): 819-820.

    Google Scholar 

  20. Su Y, Hu Y, Yang J, Yan Z, Liu M: A Retrospective Analysis on 356 Cases of Forensic Identification for Medical Dispute. West China Med J. 2009, 24 (2): 288-291.

    Google Scholar 

  21. Guo N: The study on medical damage compensation disputes in part of Primary People’s Court of Urumqi in 2008 to 2010. Xin Jiang Medical University, Social Medicine and Health Service Management. 2012

    Google Scholar 

  22. Zhang Y: Medical Injury and Medical Negligence in Obstetrical and Gyneeological Malpractice Cases. Peking Union Medical College, Department of epidemiology and statistics. 2008

    Google Scholar 

  23. Xu H: Related to Prenatal Ultrasonic Diagnosis of 120 Cases of Medical Dispute Cases Analysed and Preventive Measures. Chin J Med Ultrasound (Electronic Edition). 2011, 8 (4): 683-689.

    Google Scholar 

  24. Shaw GY, Pierce E: Malpractice Litigation Involving Iatrogenic Surgical Vocal Fold Paralysis: A Closed-Claims Review With Recommendations for Prevention and Management. Ann Otol Rhinol Laryngol. 2009, 118 (1): 6-12.

    Article  PubMed  Google Scholar 

  25. Iv N, Eikens MP, Hamersma AM, Bruijne MC: Application of Root Cause Analysis on Malpractice Claim Files Related to Diagnostic Failures. Qual Saf Health Care. 2010, 19 (e21): 1-5.

    Google Scholar 

  26. Tehrani ASS, Lee H, Mathews SC, Shore A, Makary MA, Pronovost PJ, Newman-Toker DE: 25-Year Summary of US Malpractice Claims for Diagnostic Errors 1986–2010: An Analysis From the National Practitioner Data Bank. BMJ Qual Saf. 2013, 22: 672-680. 10.1136/bmjqs-2012-001550.

    Article  Google Scholar 

  27. Carroll AE, Buddenbaum JL: Malpractice Claims Involving Pediatricians: Epidemiology and Etiology. Pediatrics. 2007, 120 (1): 10-17. 10.1542/peds.2006-3618.

    Article  PubMed  Google Scholar 

  28. Cranshaw J, Gupta KJ, Cook TM: Litigation related to drug errors in anaesthesia: an analysis of claims against the NHS in England 1995–2007. Anaesthesia. 2009, 64 (12): 1317-1323. 10.1111/j.1365-2044.2009.06107.x.

    Article  CAS  PubMed  Google Scholar 

  29. Oliver D, Killick S, Even T, Willmott M: Do falls and falls-injuries in hospital indicate negligent care – and how big is the risk? A retrospective analysis of the NHS Litigation Authority Database of clinical negligence claims, resulting from falls in hospitals in England 1995 to 2006. Qual Saf Health Care. 2008, 17 (6): 431-436. 10.1136/qshc.2007.024703.

    Article  CAS  PubMed  Google Scholar 

  30. Uesugi N, Yamanaka M, Suzuki T, Hirahara F: Analysis of birth-related medical malpractice litigation cases in Japan: Review and discussion towards implementation of a no-fault compensation system. (J Obstet Gynaecol Res. 2010, 36 (4): 717-725. 10.1111/j.1447-0756.2010.01240.x.

    Article  PubMed  Google Scholar 

  31. Yang CM, Tsai SH, Chiu WT: How risky is caring for emergency patients at risk of malpractice litigation: a population based epidemiological study of Taiwan’s experiences. BMC Health Serv Res. 2009, 9: 168-10.1186/1472-6963-9-168.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Jena AB, Seabury S, Lakdawalla D, Chandra A: Malpractice Risk According to Physician Specialty. N Engl J Med. 2011, 365: 629-636. 10.1056/NEJMsa1012370.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Najaf-Zadeh A, Dubos F, Pruvost I, Bons-Letouzey C, Amalberti R, Martinot A: Epidemiology and aetiology of paediatric malpractice claims in France. Arch Dis Child. 2011, 96 (2): 127-130. 10.1136/adc.2010.189209.

    Article  CAS  PubMed  Google Scholar 

  34. Zheng L, Jin K, Yan X, Chen Y, Dong L, Jin H, Tang J: 111 Case of The Investigation and Analysis of Medical Disputes. Chin J Hosp Admin. 2006, 22 (4): 250-252.

    Google Scholar 

  35. Li W: Analysis of 69 Cases of Medical Disputes and Protection. J Qiqihar Med Coll. 2011, 32 (1): 94-95.

    CAS  Google Scholar 

  36. Kong F, Bai R, Cui Z, Wang X, Pan L, Fan Y, Liu C, Zhang Z: Identificationg Results of 254 Cases of Medical Disputes. Chinese Hospital Management. 2011, 31 (2): 17-18.

    Google Scholar 

  37. Teo D: 7th International Association of Biological Standardization (IABS) Symposium on Advances in Transfusion Safety. Biologicals. 2012, 40: 169-169. 10.1016/j.biologicals.2012.04.001.

    Article  PubMed  Google Scholar 

  38. Wu CY, Lai HJ, Chen RC: Medical malpractice experience of Taiwan: 2005 versus 1991. Intern Med J. 2009, 39 (4): 237-242. 10.1111/j.1445-5994.2009.01801.x.

    Article  PubMed  Google Scholar 

  39. Wan L, Zhu J, Yang S: Study oR 151 Cases of Judicial ldentificalion of Medical Dispute. Med Philos. 2010, 31 (10): 64-65.

    Google Scholar 

  40. Xi C, Yang L: Medical liability laws in China: The tale of two regimes. Tort L Rev. 2011, 19: 65-75.

    Google Scholar 

  41. Kelly CN, Mello MM: Are Medical Malpractice Damages Caps Constitutional? An Overview of State Litigation. J Law Med Ethics. 2005, 33 (3): 513-534.

    Article  Google Scholar 

Pre-publication history

Download references


We acknowledge the outstanding contributions from Xiangcheng Wu and Tao Sun, who contributed equally as the first author to this article. This study was funded by grants from the HarBin Science and Technology Bureau (Grant No.2013RFQXJ071) and National Natural Science Foundation of China (Grant No. 71473063). The funding agency did not play a role in design, conducting, or analysis of the research. The decision to submit the manuscript for publication was that of the authors.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Lihua Fan.

Additional information

Competing interest

The authors declare that they have no competing interests.

Authors’ contribution

LH carred out the literature search, figures, study design, data collection, data analysis, data interpretation, writing. WXC participated in literature search, figures, study design, data collection, data analysis, data interpretation, writing. FLH participated in study design and data interpretation. ST contributes to literature search, data collection, data analysis. LL participated in literature search, figures, and study design. ZXW participated in collection, data analysis. LXY participated in literature search, data analysis. GL participated in data collection, data analysis, data interpretation. SQS participated in study design, data collection, data analysis. ZZ participated in data collection, data analysis, data interpretation. All authors read and approved the final manuscript.

Heng Li, Xiangcheng Wu, Tao Sun contributed equally to this work.

Authors’ original submitted files for images

Rights and permissions

Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver ( ) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, H., Wu, X., Sun, T. et al. Claims, liabilities, injures and compensation payments of medical malpractice litigation cases in China from 1998 to 2011. BMC Health Serv Res 14, 390 (2014).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: